Coronary Stents Market Analysis | CMI

1

• Coherent Market Insights
• Market Research and Business Consulting Services
• https//www.coherentmarketinsights.com/
• COVID-19 Impact Tracker

2
CORONARY STENTS MARKET ANALYSIS

• Coronary Stents Market, By Product Type
  (Bare-metal Stents, Drug Eluting Stents, and
  Bioabsorbable Stents), By Material (Metallic
  (Stainless Steel, Silicon Carbide, Titanium
  Nitride Oxide, Cobalt Chromium, Platinum
  Chromium, and Others) and Polymeric
  (Non-degradable/Permanent Stents and
  Degradable/Temporary Stents)), By End User
  (Hospitals, Specialty Clinics, and Ambulatory
  Surgical Centers), and By Region (North America,
  Latin America, Europe, Asia Pacific, Middle East,
  and Africa) - Size, Share, Outlook, and
  Opportunity Analysis, 2020 - 2027
• The global coronary stents market is estimated to
  be valued at US 8,985.6 million in 2020 and is
  expected to exhibit a CAGR of 7.7 during the
  forecast period (2020-2027).

3
Figure 1. Global Coronary Stents Market Share
() in Terms of Value, By Region, 2020
4
Market Drivers

• The increasing prevalence of coronary heart
  disease is expected to drive the market growth
  during the forecast period
• Coronary heart disease (CHD) is usually caused by
  a build-up of fatty deposits (atheroma) on the
  walls of the arteries around the heart (coronary
  arteries). The build-up of atheroma makes the
  arteries narrower, restricting the flow of blood
  to the heart muscle. This process is called
  atherosclerosis. Thus, the rising prevalence of
  coronary heart disease is increasing demand for
  coronary stents for management of coronary heart
  diseases.
• According to the World Health Organizations 2017
  report, cardiovascular diseases (CVDs) were the
  number 1 cause of death globally, and around 17.9
  million individuals died due to cardiovascular
  diseases in 2016. CVDs are a group of disorders
  of the heart and blood vessels and include
  coronary heart disease, cerebrovascular disease,
  rheumatic heart disease and other conditions.
• Moreover, according to the U.S. Department of
  Health Human Services report, coronary heart
  disease is the most common type of heart disease
  in the U.S. In 2017, around 3,65,914 people died
  due to coronary heart disease in the U.S.

5
Figure 2. Global Coronary Stents Market Share
(), by Product Type, 2020
6

• Launch and approval of novel products is expected
  to drive the market growth during the forecast
  period
• Key players operating in the global Coronary
  Stents Market are focusing on product launches
  and obtaining regulatory approval for novel
  coronary stents which is expected to drive the
  market growth during the forecast period
• For instance, in February 2019, Medtronic PLC
  received an approval from the U.S. Food and Drug
  Administration for its Resolute Drug-Eluting
  Stent (DES) platform (including the Resolute Onyx
  and Resolute Integrity DES) for treatment of
  patients with coronary artery disease who have de
  novo chronic total occlusion (CTO), a complex
  vessel condition of complete blockage of a
  coronary artery. CTO is considered more difficult
  to treat with percutaneous coronary intervention
  (PCI) due to a greater risk of complications.

7
(No Transcript)
8

• In September 2019, OrbusNeich Medical K.K., a
  Japan-based company, received approval for its
  COMBO Plus Coronary Stent from the Japan Ministry
  of Health, Labor, and Welfare (MHLW). The COMBO
  Plus Coronary Stent is the first drug-eluting
  stent DES to combine the proprietary
  endothelial progenitor cell EPC capture
  technology with an abluminal sirolimus drug
  elution delivered from a biodegradable matrix
  polymer that achieves full and complete
  dissipation in 90 days.
• Moreover, in May 2019, Medtronic Plc launched the
  Telescope Guide Extension Catheter. The extension
  catheters help to deliver coronary stents,
  balloons and other interventional devices during
  angioplasty procedures that help to restore blood
  flow through the coronary and peripheral
  arteries.

9
Global Coronary Stents Market Impact of
Coronavirus (Covid-19) Pandemic

• Since the COVID-19 virus outbreak in December
  2019, the disease has spread to over 100
  countries around the globe with the World Health
  Organization declaring it a public health
  emergency. According to the World Health
  Organizations report, the manifestation of
  COVID-19 has resulted in more than 20.6 million
  infected individuals worldwide as of 13 August
  13, 2020. Furthermore, the global COVID-19
  pandemic has led to a sudden pause in
  manufacturing activities across the globe,
  thereby affecting demand for coronary stents, as
  well as production and processing of coronary
  stents.

10
Market Restraint

• Factors such as risky stent implantation and
  complications associated with implantation of
  stents is expected to negatively affect growth of
  the market. For instance, stents implantation is
  prone to stents displacement and re-narrowing of
  the arteries. Re-blockages are addressed by
  administering blood-thinning drugs, which is
  leading to high adoption of drug eluting coronary
  stents.

11
Key Players

• Major players operating in the global medical
  metal tubing market are Boston Scientific
  Corporation, Abbott, Medtronic plc, B. Braun
  Melsungen AG, Stentsy SA, Terumo Interventional
  Systems, Kyoto Medical Planning Co., Ltd.,
  QualiMed, Elixir Medical Corporation, ENDOCOR
  GmbH, BIOTRONIK SE Co. KG, Amaranth Medical,
  Inc. and Arterial Remodeling Technologies SA

12

• Request Sample Report
• Request Customization
• Download PDF Brochure
• Talk to Analyst
• Reference https//www.coherentmarketinsights.com
  /market-insight/coronary-stents-market-2031

13
About Us

• Coherent Market Insights is a global market
  intelligence and consulting organization focused
  on assisting our plethora of clients achieve
  transformational growth by helping them make
  critical business decisions.
• What we provide
• Customized Market Research Services
• Industry Analysis Services
• Business Consulting Services
• Market Intelligence Services
• Long term Engagement Model
• Country Specific Analysis

14
Contact Us

• Mr. Shah
• Coherent Market Insights Pvt.Ltd.
• Address 1001 4th Ave, 3200 Seattle, WA 98154,
  U.S.
• Phone [phone]
• Email sales_at_coherentmarketinsights.com

15

• Thank You!
• Kindly follow CMI Social Media Profiles
  for the latest company updates
• Facebook
• Linkedin
• Twitter
• https//www.coherentmarketinsights.com/